UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early effect of fractional CO2 laser treatment in Post-menopausal women with vaginal atrophy

LASER THERAPY, 2018, Vol.27(1), pp.41-47

Eder, Scott Evan

2018

Volltextzugriff (PDF)

Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial

Obstetrics and gynecology (New York. 1953), 2010-10, Vol.116 (4), p.865-875

2010

Volltextzugriff (PDF)

Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage

Women's Health, 2017-12, Vol.13 (3), p.58-67

2017

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Laser therapy, 2019-06, Vol.28 (2), p.103-109

Eder, Scott Evan

2019

Volltextzugriff (PDF)

Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers

International journal of gynecology and obstetrics, 2017-05, Vol.137 (2), p.107-109

2017

Volltextzugriff (PDF)

Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid

Journal of virological methods, 2011-03, Vol.172 (1), p.27-31

2011

Volltextzugriff (PDF)

The Long Term Safety and Efficacy of the FemTouch for the Treatment of Vulvovaginal Atrophy in Postmenopausal Women [20M]

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (1), p.146-146S

Eder, Scott Evan

2019

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Fractional CO 2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Laser therapy, 2019-06, Vol.28 (2), p.103

Eder, Scott Evan

2019

Volltextzugriff (PDF)

Secnidazole, an Approved Single Dose Drug for Bacterial Vaginosis, Does Not Cause Reproductive Toxicity in Animals [16A]

Obstetrics and gynecology (New York. 1953), 2020-05, Vol.135 (1), p.12-12S

2020

Volltextzugriff (PDF)

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy: Fractional CO2 laser in Vaginal atrophy 18m FU

LASER THERAPY, 2019, Vol.28(2), pp.103-109

Eder, Scott Evan

2019

Volltextzugriff (PDF)

Early effect of fractional CO 2 laser treatment in Post-menopausal women with vaginal atrophy

Laser therapy, 2018-03, Vol.27 (1), p.41

Eder, Scott Evan

2018

Volltextzugriff (PDF)

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Menopause (New York, N.Y.), 2016-03, Vol.23 (3), p.243-256

2016

Volltextzugriff (PDF)

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study

Clinical infectious diseases, 2021-09, Vol.73 (6), p.e1282-e1289

2021

Volltextzugriff (PDF)

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Menopause (New York, N.Y.), 2013-06, Vol.20 (6), p.623-630

2013

Volltextzugriff (PDF)

Evaluation of the EmbaGYN™ pelvic floor muscle stimulator in addition to Kegel exercises for the treatment of female stress urinary incontinence: a prospective, open-label, multicenter, single-arm study

Women's health (London, England), 2014-01, Vol.10 (1), p.17-27

Eder, Scott Evan

2014

Volltextzugriff (PDF)

Ospemifene: a novel selective estrogen receptor modulator for treatment of dyspareunia

Women's health (London, England), 2014-09, Vol.10 (5), p.499-503

Eder, Scott Evan

2014

Volltextzugriff (PDF)

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy

Journal of sexual medicine, 2015-12, Vol.12 (12), p.2401-2412

2015

Volltextzugriff (PDF)

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Menopause (New York, N.Y.), 2018-11, Vol.25 (11), p.1339-1353

2018

Volltextzugriff (PDF)

The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 μg ethinyl estradiol versus monophasic levonorgestrel/20 μg ethinyl estradiol

Contraception (Stoneham), 2002-09, Vol.66 (3), p.147-152

2002

Volltextzugriff (PDF)

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Maturitas, 2014-03, Vol.77 (3), p.274-281

2014

Volltextzugriff (PDF)

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Women's health (London, England), 2012-09, Vol.8 (5), p.503-511

2012

Volltextzugriff (PDF)

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner

Climacteric : the journal of the International Menopause Society, 2015-11, Vol.18 (6), p.817-825

2015

Volltextzugriff (PDF)

Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids

Women's health (London, England), 2013-07, Vol.9 (4), p.397-403

2013

Volltextzugriff (PDF)

Varicella Pneumonia During Pregnancy

American journal of perinatology, 1988-01, Vol.5 (1), p.16-18

1988

Volltextzugriff (PDF)

The effect of extending the pill-free interval on follicular activity

Contraception (Stoneham), 2002-09, Vol.66 (3), p.147-152

2002

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early effect of fractional CO2 laser treatment in Post-menopausal women with vaginal atrophy

Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial

Role of female intimate hygiene in vulvovaginal health: Global hygiene practices and product usage

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers

Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid

The Long Term Safety and Efficacy of the FemTouch for the Treatment of Vulvovaginal Atrophy in Postmenopausal Women [20M]

Long-Term Safety and Efficacy of Fractional CO 2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy

Secnidazole, an Approved Single Dose Drug for Bacterial Vaginosis, Does Not Cause Reproductive Toxicity in Animals [16A]

Long-Term Safety and Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women with Vaginal Atrophy: Fractional CO2 laser in Vaginal atrophy 18m FU

Early effect of fractional CO 2 laser treatment in Post-menopausal women with vaginal atrophy

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study

Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

Evaluation of the EmbaGYN™ pelvic floor muscle stimulator in addition to Kegel exercises for the treatment of female stress urinary incontinence: a prospective, open-label, multicenter, single-arm study

Ospemifene: a novel selective estrogen receptor modulator for treatment of dyspareunia

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 μg ethinyl estradiol versus monophasic levonorgestrel/20 μg ethinyl estradiol

Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner

Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids

Varicella Pneumonia During Pregnancy

The effect of extending the pill-free interval on follicular activity

Suchergebnisse filtern